Vildagliptin for Treatment of Antipsychotic-induced Dyslipidemia

NCT04761861 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Institutional and funding constrains

Conditions

Schizophrenia
Dyslipidemias

Interventions

DRUG: Vildagliptin 50 MG
DRUG: Placebo

Sponsor

Sadat City University